# Ondansetron Versus Lidocaine for Preventing Pain on Propofol Injection.

> **NCT07632144** · NA · NOT_YET_RECRUITING · sponsor: **Mongi Slim Hospital** · enrollment: 156 (estimated)

## Conditions studied

- Anesthesia Induction
- Propofol Pain Injection

## Interventions

- **DRUG:** Group C (Control)
- **DRUG:** Ondansetron 8 mg
- **DRUG:** Lidocaine %2 ampoule

## Key facts

- **NCT ID:** NCT07632144
- **Lead sponsor:** Mongi Slim Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-08
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-08-15
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07632144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07632144, "Ondansetron Versus Lidocaine for Preventing Pain on Propofol Injection.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07632144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
